MAPK3 and cytomegalovirus infection: On the other hand, eight out of ten anti-COVID-19 core targets (TNF, EGFR, CASP3, AKT1, MAPK1, MAPK3, mTOR, and IL-6) followed the human cytomegalovirus infection.